Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

A new topical treatment for hair loss shows promise by targeting androgen receptors.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

RXR and RAR proteins in skin may help with cell growth, hair growth, and gland function.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Retinoids may improve hair growth in androgenic alopecia when used with other treatments.

RCS-01 is safe and may help rejuvenate aging skin.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Squaric acid dibutylester effectively treats alopecia areata.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Troxerutin helps protect skin cells from oxidative stress and may be good for treating hair loss.

Steroid 12 shows promise as a targeted treatment for prostate cancer by selectively reducing cell growth and increasing cell death.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.